Free Trial

iRhythm Technologies (IRTC) Financials

iRhythm Technologies logo
$146.37 +3.68 (+2.58%)
Closing price 04:00 PM Eastern
Extended Trading
$144.57 -1.80 (-1.23%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for iRhythm Technologies

Annual Income Statements for iRhythm Technologies

This table shows iRhythm Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
-113 -123 -116 -101 -44 -55 -50 -30 -21 -23
Consolidated Net Income / (Loss)
-113 -123 -116 -101 -44 -55 -50 -30 -21 -23
Net Income / (Loss) Continuing Operations
-113 -123 -116 -101 -44 -55 -50 -30 -21 -23
Total Pre-Tax Income
-113 -123 -116 -101 -44 -55 -50 -30 -21 -23
Total Operating Income
-116 -125 -114 -100 -44 -55 -46 -28 -16 -22
Total Gross Profit
408 332 282 214 195 162 108 71 43 21
Total Revenue
592 493 411 323 265 215 147 99 64 36
Operating Revenue
592 493 411 323 265 215 147 99 64 36
Total Cost of Revenue
184 161 129 109 70 52 39 28 21 15
Operating Cost of Revenue
184 161 129 109 70 52 39 28 21 15
Total Operating Expenses
523 457 395 314 239 217 154 99 59 43
Selling, General & Admin Expense
419 386 322 275 197 180 133 85 52 37
Research & Development Expense
104 60 47 39 41 37 21 13 7.15 6.35
Restructuring Charge
0.64 11 27 0.00 - - - - - -
Total Other Income / (Expense), net
2.78 2.51 -2.10 -1.05 0.07 0.25 -4.64 -2.15 -5.32 -1.06
Interest Expense
20 3.65 4.14 1.17 1.52 1.64 6.14 3.39 3.25 1.06
Interest & Investment Income
22 6.35 2.35 - - - - - - -
Other Income / (Expense), net
1.25 -0.20 -0.31 0.12 1.59 1.90 1.50 1.24 -2.07 -
Income Tax Expense
0.57 0.75 0.27 0.37 0.23 0.07 0.04 0.00 0.00 -
Basic Earnings per Share
($3.63) ($4.04) ($3.88) ($3.46) ($1.58) ($2.16) ($2.11) ($1.31) ($3.95) ($16.57)
Weighted Average Basic Shares Outstanding
31.20M 30.53M 29.92M 29.33M 27.75M 25.27M 23.89M 22.63M 5.29M 1.38M
Diluted Earnings per Share
($3.63) ($4.04) ($3.88) ($3.46) ($1.58) ($2.16) ($2.11) ($1.31) ($3.95) ($16.57)
Weighted Average Diluted Shares Outstanding
31.20M 30.53M 29.92M 29.33M 27.75M 25.27M 23.89M 22.63M 5.29M 1.38M
Weighted Average Basic & Diluted Shares Outstanding
31.41M 30.98M 30.22M 29.51M 27.75M 25.27M 23.89M 22.63M 5.29M 1.38M

Quarterly Income Statements for iRhythm Technologies

This table shows iRhythm Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
-31 -1.33 -46 -20 -46 -39 -27 -18 -39 -20 -21
Consolidated Net Income / (Loss)
-31 -1.33 -46 -20 -46 -39 -27 -18 -39 -20 -21
Net Income / (Loss) Continuing Operations
-31 -1.33 -46 -20 -46 -39 -27 -18 -39 -20 -21
Total Pre-Tax Income
-30 -1.18 -46 -20 -46 -38 -27 -18 -39 -20 -21
Total Operating Income
-33 -4.08 -50 -23 -38 -39 -28 -19 -40 -21 -21
Total Gross Profit
109 115 101 103 88 87 82 86 76 79 71
Total Revenue
159 164 148 148 132 133 125 124 111 113 104
Operating Revenue
159 164 148 148 132 133 125 124 111 113 104
Total Cost of Revenue
49 49 46 45 44 45 42 38 36 34 33
Operating Cost of Revenue
49 49 46 45 44 45 42 38 36 34 33
Total Operating Expenses
142 119 152 126 126 127 110 105 115 99 92
Selling, General & Admin Expense
120 100 103 107 109 100 94 91 100 87 81
Research & Development Expense
22 19 48 20 17 15 16 14 15 13 11
Total Other Income / (Expense), net
2.52 2.90 4.31 3.07 -7.50 0.74 0.68 0.60 0.48 0.57 -0.25
Interest Expense
3.27 3.32 3.33 3.31 10 0.94 0.93 0.83 0.95 1.01 0.61
Interest & Investment Income
4.92 - 6.46 - - - 1.72 - - - 0.37
Other Income / (Expense), net
0.88 -9.26 1.18 6.38 2.95 -2.96 -0.11 1.44 1.43 - -
Income Tax Expense
0.67 0.15 0.19 0.19 0.03 0.26 0.20 0.21 0.09 0.07 0.12
Basic Earnings per Share
($0.97) ($0.03) ($1.48) ($0.65) ($1.47) ($1.25) ($0.89) ($0.61) ($1.29) ($0.66) ($0.71)
Weighted Average Basic Shares Outstanding
31.59M 31.20M 31.26M 31.15M 31.03M 30.53M 30.61M 30.50M 30.30M 29.92M 30.06M
Diluted Earnings per Share
($0.97) ($0.03) ($1.48) ($0.65) ($1.47) ($1.25) ($0.89) ($0.61) ($1.29) ($0.66) ($0.71)
Weighted Average Diluted Shares Outstanding
31.59M 31.20M 31.26M 31.15M 31.03M 30.53M 30.61M 30.50M 30.30M 29.92M 30.06M
Weighted Average Basic & Diluted Shares Outstanding
31.93M 31.41M 31.30M 31.24M 31.10M 30.98M 30.65M 30.58M 30.47M 30.22M 30.11M

Annual Cash Flow Statements for iRhythm Technologies

This table details how cash moves in and out of iRhythm Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
392 -43 -49 39 0.44 11 -43 26 17
Net Cash From Operating Activities
3.39 -50 -23 -38 -22 -29 -15 -17 -18
Net Cash From Continuing Operating Activities
3.39 -50 -23 -38 -22 -29 -15 -17 -18
Net Income / (Loss) Continuing Operations
-113 -123 -116 -101 -55 -50 -30 -21 -23
Consolidated Net Income / (Loss)
-113 -123 -116 -101 -55 -50 -30 -21 -23
Depreciation Expense
21 16 13 9.84 3.45 2.27 1.60 0.57 0.49
Amortization Expense
6.51 0.77 5.77 8.39 8.11 -0.70 -0.09 0.26 0.12
Non-Cash Adjustments To Reconcile Net Income
180 152 136 92 51 33 21 10 3.02
Changes in Operating Assets and Liabilities, net
-91 -96 -62 -46 -30 -13 -7.21 -6.73 1.16
Net Cash From Investing Activities
-123 -1.21 -52 105 -89 34 -35 -68 -1.79
Net Cash From Continuing Investing Activities
-123 -1.21 -52 105 -89 34 -35 -68 -1.79
Purchase of Property, Plant & Equipment
-34 -40 -30 -28 -20 -5.18 -3.56 -2.76 -1.79
Acquisitions
-15 0.00 0.00 - - - - - -
Purchase of Investments
-175 -167 -189 -122 -166 -93 -130 -65 -
Sale and/or Maturity of Investments
101 207 166 256 97 132 99 - -
Net Cash From Financing Activities
511 8.82 27 -29 112 6.30 6.53 111 36
Net Cash From Continuing Financing Activities
511 8.82 27 -29 112 6.30 6.53 111 36
Repayment of Debt
-136 0.00 -21 -12 0.00 -34 0.00 - -4.91
Repurchase of Common Equity
-25 0.00 0.00 - - - - - -
Issuance of Debt
736 0.00 35 0.00 - 35 0.00 - 29
Issuance of Common Equity
8.47 8.82 13 8.94 9.50 9.32 - 114 -
Other Financing Activities, net
-72 0.00 0.00 -26 102 -3.88 6.53 -3.18 0.30
Other Net Changes in Cash
-0.01 -0.17 0.00 - - - - - -
Cash Interest Paid
6.39 2.96 3.32 1.19 1.64 6.07 1.55 1.59 0.34
Cash Income Taxes Paid
0.92 1.13 0.29 0.00 - - - - -

Quarterly Cash Flow Statements for iRhythm Technologies

This table details how cash moves in and out of iRhythm Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
-44 -100 -31 30 493 -11 -14 8.77 -26 7.61 -30
Net Cash From Operating Activities
-7.89 19 24 12 -52 -16 1.20 -4.57 -31 13 3.67
Net Cash From Continuing Operating Activities
-7.89 19 24 12 -52 -16 1.20 -4.57 -31 13 3.67
Net Income / (Loss) Continuing Operations
-31 -1.33 -46 -20 -46 -39 -27 -18 -39 -20 -21
Consolidated Net Income / (Loss)
-31 -1.33 -46 -20 -46 -39 -27 -18 -39 -20 -21
Depreciation Expense
5.21 5.29 5.14 5.16 5.13 4.91 4.07 3.79 3.58 3.48 3.44
Amortization Expense
1.57 1.82 2.02 1.75 0.91 0.14 0.08 0.32 0.23 0.69 -3.15
Non-Cash Adjustments To Reconcile Net Income
50 34 64 40 43 51 33 28 40 27 35
Changes in Operating Assets and Liabilities, net
-34 -20 -0.65 -15 -55 -33 -8.98 -19 -35 1.46 -10
Net Cash From Investing Activities
-38 -122 -55 15 40 1.40 -15 9.01 3.82 -8.11 -35
Net Cash From Continuing Investing Activities
-38 -122 -55 15 40 1.40 -15 9.01 3.82 -8.11 -35
Purchase of Property, Plant & Equipment
-9.42 -6.84 -8.83 -8.49 -9.78 -14 -9.09 -9.40 -8.42 -7.09 -6.33
Purchase of Investments
-34 -118 -40 -15 -2.43 -55 -36 -42 -34 -51 -46
Sale and/or Maturity of Investments
5.60 2.50 8.50 38 52 70 30 61 46 50 17
Net Cash From Financing Activities
1.73 2.99 -0.04 3.79 505 3.47 0.07 4.38 0.91 3.15 1.66
Net Cash From Continuing Financing Activities
1.73 2.99 -0.04 3.79 505 3.47 0.07 4.38 0.91 3.15 1.66
Repayment of Debt
0.00 - -0.18 -0.95 -135 - - - 0.00 - -
Repurchase of Common Equity
0.00 - - - -25 - - - 0.00 - -
Issuance of Debt
0.00 - - - 736 - - - 0.00 - -
Issuance of Common Equity
1.73 2.99 0.15 4.73 0.60 3.47 0.07 4.38 0.91 3.15 1.66
Other Financing Activities, net
0.00 - - - -72 - - - 0.00 - -
Other Net Changes in Cash
-0.02 0.00 0.01 -0.01 -0.00 -0.20 0.08 -0.04 0.00 - -
Cash Interest Paid
4.96 - 4.79 - 1.60 0.77 0.77 0.74 0.68 0.64 0.46
Cash Income Taxes Paid
0.39 0.32 0.24 0.35 0.01 0.34 0.51 0.28 0.01 0.29 -

Annual Balance Sheets for iRhythm Technologies

This table presents iRhythm Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets
931 433 448 463 512 306 118 133 138 38
Total Current Assets
646 231 289 306 378 173 104 120 119 33
Cash & Equivalents
420 36 79 128 89 20 20 - 52 25
Short-Term Investments
116 98 134 112 247 120 58 - 54 -
Accounts Receivable
80 61 50 46 30 24 20 13 9.41 5.58
Inventories, net
14 14 15 10 5.31 4.04 2.06 - 1.39 1.15
Prepaid Expenses
16 22 11 9.69 7.36 4.34 4.10 - 1.67 0.81
Plant, Property, & Equipment, net
125 104 76 56 34 26 9.16 6.30 4.65 2.04
Total Noncurrent Assets
161 98 84 102 100 107 4.07 0.00 15 3.01
Long-Term Investments
62 3.00 - - - 8.03 0.00 - 11 -
Goodwill
0.86 0.86 0.86 0.86 0.86 0.86 0.86 - 0.86 0.86
Other Noncurrent Operating Assets
98 94 83 101 99 98 3.21 - 3.05 2.15
Total Liabilities & Shareholders' Equity
931 433 448 463 512 306 118 133 138 38
Total Liabilities
841 223 208 183 170 171 65 70 46 42
Total Current Liabilities
111 107 89 88 66 52 30 21 13 8.78
Accounts Payable
7.22 5.54 7.52 11 4.37 8.24 2.28 - 2.10 1.46
Accrued Expenses
85 83 65 51 41 33 27 16 10 6.70
Current Deferred Revenue
2.93 3.31 3.05 3.05 0.93 1.25 1.22 - 0.95 0.51
Other Current Liabilities
16 15 13 11 8.17 7.91 0.00 - - -
Total Noncurrent Liabilities
730 116 119 96 104 119 35 54 32 34
Long-Term Debt
646 35 35 9.69 21 33 35 - 32 31
Other Noncurrent Operating Liabilities
83 81 84 86 83 86 0.00 54 0.13 3.05
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Total Equity & Noncontrolling Interests
91 210 240 280 342 135 52 -157 93 -102
Total Preferred & Common Equity
91 210 240 280 342 135 52 79 93 -102
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Total Common Equity
91 210 240 280 342 135 52 -157 93 -102
Common Stock
875 856 762 686 646 396 258 - 220 4.64
Retained Earnings
-759 -646 -522 -406 -305 -260 -206 -157 -127 -106
Treasury Stock
-25 0.00 - - - - - - - -
Accumulated Other Comprehensive Income / (Loss)
0.17 -0.11 -0.40 -0.06 0.01 0.08 -0.02 - -0.01 -

Quarterly Balance Sheets for iRhythm Technologies

This table presents iRhythm Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
926 910 919 910 440 429 422 440
Total Current Assets
636 628 678 687 234 242 254 286
Cash & Equivalents
375 520 551 520 47 62 53 71
Short-Term Investments
145 2.50 11 49 111 103 124 132
Accounts Receivable
81 77 86 90 50 51 50 61
Inventories, net
14 15 15 15 14 14 16 14
Prepaid Expenses
20 13 15 14 12 12 12 7.33
Plant, Property, & Equipment, net
131 122 118 112 97 90 82 72
Total Noncurrent Assets
159 159 124 110 109 98 86 83
Long-Term Investments
63 59 - - - - - -
Goodwill
0.86 0.86 0.86 0.86 0.86 0.86 0.86 0.86
Other Noncurrent Operating Assets
96 99 123 109 108 97 85 82
Total Liabilities & Shareholders' Equity
926 910 919 910 440 429 422 440
Total Liabilities
839 838 820 819 220 206 200 201
Total Current Liabilities
111 100 98 97 102 89 82 84
Accounts Payable
12 7.59 13 8.44 7.21 7.15 9.78 7.40
Accrued Expenses
80 74 66 70 77 64 55 60
Current Deferred Revenue
3.28 3.03 3.15 3.07 3.38 3.70 3.49 3.00
Other Current Liabilities
16 16 15 15 15 14 14 13
Total Noncurrent Liabilities
728 738 722 723 118 116 118 118
Long-Term Debt
647 646 645 644 35 35 35 35
Other Noncurrent Operating Liabilities
81 92 77 79 83 81 83 83
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
87 72 99 90 220 224 222 239
Total Preferred & Common Equity
87 72 99 90 220 224 222 239
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
87 72 99 90 220 224 222 239
Common Stock
901 854 835 807 827 804 783 742
Retained Earnings
-790 -758 -711 -691 -607 -580 -561 -502
Treasury Stock
-25 -25 -25 -25 - - - -
Accumulated Other Comprehensive Income / (Loss)
0.14 -0.07 0.18 -0.09 -0.02 -0.15 -0.07 -0.68

Annual Metrics And Ratios for iRhythm Technologies

This table displays calculated financial ratios and metrics derived from iRhythm Technologies' official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
20.13% 19.90% 27.29% 21.74% 23.59% 45.68% 48.57% 54.72% 77.29% 66.17%
EBITDA Growth
19.60% -14.03% -16.34% -184.07% 30.47% 3.07% -71.51% -47.65% 19.94% -45.87%
EBIT Growth
8.86% -9.87% -14.30% -137.22% 20.39% -19.62% -67.68% -49.27% 18.38% -46.50%
NOPAT Growth
7.71% -10.00% -13.85% -128.84% 20.24% -19.84% -65.60% -77.07% 27.96% -46.50%
Net Income Growth
8.20% -6.24% -14.60% -131.26% 19.68% -8.32% -69.39% -42.28% 8.32% -44.01%
EPS Growth
10.15% -4.12% -12.14% -118.99% 26.85% -2.37% -61.07% 66.84% 76.16% -37.51%
Operating Cash Flow Growth
106.77% -117.72% 39.05% -174.39% 37.07% 24.85% -95.11% 10.45% 7.52% -15.22%
Free Cash Flow Firm Growth
16.25% -68.90% 13.86% -91.45% 5.94% 44.00% -334.27% 320.28% -11.02% 0.00%
Invested Capital Growth
29.19% 75.78% -0.22% 56.70% 81.06% 146.39% 117.41% -761.54% 817.11% 0.00%
Revenue Q/Q Growth
5.68% 4.21% 8.11% 0.94% 8.03% 8.78% 9.66% 11.34% 0.00% 0.00%
EBITDA Q/Q Growth
21.98% -19.61% 9.74% -36.33% 24.18% -5.74% -1.54% -24.19% 0.00% 0.00%
EBIT Q/Q Growth
16.42% -17.51% 8.93% -29.74% 15.29% -8.71% -1.49% -25.51% 0.00% 0.00%
NOPAT Q/Q Growth
23.31% -17.33% 9.18% -29.25% 15.72% -9.25% -4.94% -31.40% 0.00% 0.00%
Net Income Q/Q Growth
24.80% -17.64% 9.57% -29.09% 14.86% -1.92% -10.53% -21.20% 0.00% 0.00%
EPS Q/Q Growth
25.15% -17.10% 10.39% -29.59% 18.13% 0.00% 0.00% -123.99% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
110.66% -132.45% 52.68% -123.52% 47.96% -2.28% -2.29% -22.97% 21.85% 0.00%
Free Cash Flow Firm Q/Q Growth
22.78% -33.86% 16.28% -22.71% 23.03% 52.05% -346.99% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
2.49% 12.48% -12.76% -2.53% -6.75% 36.94% 115.80% -536.34% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - -
Gross Margin
68.86% 67.35% 68.54% 66.16% 73.50% 75.54% 73.66% 71.55% 67.41% 59.32%
EBITDA Margin
-14.70% -21.97% -23.10% -25.27% -10.83% -19.25% -28.94% -25.07% -26.27% -58.17%
Operating Margin
-19.52% -25.40% -27.69% -30.96% -16.47% -25.52% -31.02% -27.83% -24.32% -59.85%
EBIT Margin
-19.30% -25.44% -27.77% -30.92% -15.87% -24.64% -30.00% -26.59% -27.55% -59.85%
Profit (Net Income) Margin
-19.14% -25.05% -28.27% -31.40% -16.53% -25.43% -34.21% -30.00% -32.62% -63.09%
Tax Burden Percent
100.50% 100.61% 100.23% 100.36% 100.53% 100.12% 100.09% 100.00% 100.00% 100.48%
Interest Burden Percent
98.66% 97.84% 101.57% 101.17% 103.61% 103.11% 113.90% 112.85% 118.40% 104.90%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-65.16% -103.14% -129.15% -138.34% -99.97% -250.57% 0.00% 0.00% -256.55% -3,622.42%
ROIC Less NNEP Spread (ROIC-NNEP)
57.64% -77.58% -110.71% -126.26% -93.59% -229.88% 0.00% 0.00% -231.42% -3,907.92%
Return on Net Nonoperating Assets (RNNOA)
-10.12% 48.28% 84.42% 105.70% 81.59% 192.38% 0.00% 0.00% 209.07% 4,629.44%
Return on Equity (ROE)
-75.27% -54.86% -44.73% -32.64% -18.38% -58.19% 96.27% 92.59% -47.49% 1,007.02%
Cash Return on Invested Capital (CROIC)
-90.63% -158.10% -128.93% -182.52% -157.65% -335.09% -1,036.41% 0.00% -417.23% -3,822.42%
Operating Return on Assets (OROA)
-16.75% -28.45% -25.04% -20.48% -10.29% -24.95% -35.22% -19.41% -20.06% -57.12%
Return on Assets (ROA)
-16.60% -28.00% -25.50% -20.80% -10.72% -25.76% -40.16% -21.91% -23.75% -60.20%
Return on Common Equity (ROCE)
-75.27% -54.86% -44.73% -32.64% -18.38% -58.19% 96.27% 92.59% 4.89% 22,601.08%
Return on Equity Simple (ROE_SIMPLE)
-124.62% -58.74% -48.44% -36.26% -12.83% -40.30% -96.63% -37.48% -22.58% 22.43%
Net Operating Profit after Tax (NOPAT)
-81 -88 -80 -70 -31 -38 -32 -19 -11 -15
NOPAT Margin
-13.66% -17.78% -19.38% -21.67% -11.53% -17.86% -21.72% -19.48% -17.02% -41.90%
Net Nonoperating Expense Percent (NNEP)
-122.80% -25.56% -18.44% -12.08% -6.38% -20.69% 58.60% 98.43% -25.14% 285.51%
Return On Investment Capital (ROIC_SIMPLE)
-10.97% -35.75% -28.99% - - - - - - -
Cost of Revenue to Revenue
31.14% 32.65% 31.46% 33.84% 26.50% 24.46% 26.34% 28.45% 32.59% 40.68%
SG&A Expenses to Revenue
70.72% 78.27% 78.41% 85.14% 74.38% 83.67% 90.52% 86.00% 80.57% 101.61%
R&D to Revenue
17.54% 12.23% 11.34% 11.98% 15.59% 17.38% 14.16% 13.38% 11.16% 17.57%
Operating Expenses to Revenue
88.37% 92.75% 96.23% 97.11% 89.97% 101.06% 104.68% 99.38% 91.73% 119.18%
Earnings before Interest and Taxes (EBIT)
-114 -125 -114 -100 -42 -53 -44 -26 -18 -22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-87 -108 -95 -82 -29 -41 -43 -25 -17 -21
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
31.04 15.62 11.76 12.39 20.05 13.39 32.23 0.00 7.17 0.00
Price to Tangible Book Value (P/TBV)
31.34 15.68 11.80 12.43 20.10 13.47 32.77 0.00 7.24 0.00
Price to Revenue (P/Rev)
4.77 6.66 6.86 10.73 25.83 8.45 11.41 12.99 10.36 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
20.52 29.36 42.89 52.56 166.15 78.09 185.32 0.00 75.51 0.00
Enterprise Value to Revenue (EV/Rev)
4.85 6.45 6.43 10.05 24.69 7.92 11.11 12.99 9.04 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
846.94 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 32.97 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
7.11 0.17 0.15 0.08 0.10 0.26 0.67 0.00 0.35 -6.75
Long-Term Debt to Equity
7.11 0.17 0.15 0.03 0.06 0.24 0.67 0.00 0.35 -6.75
Financial Leverage
-0.18 -0.62 -0.76 -0.84 -0.87 -0.84 -0.60 -0.33 -0.90 -1.18
Leverage Ratio
4.53 1.96 1.75 1.57 1.71 2.26 -2.40 -4.23 2.00 -8.36
Compound Leverage Factor
4.47 1.92 1.78 1.59 1.78 2.33 -2.73 -4.77 2.37 -8.77
Debt to Total Capital
87.67% 14.26% 12.72% 7.10% 8.81% 20.51% 40.10% 0.00% 25.83% 117.40%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 3.88% 3.11% 1.14% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
87.67% 14.26% 12.72% 3.22% 5.70% 19.37% 40.10% 0.00% 25.83% 117.40%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 373.10%
Common Equity to Total Capital
12.33% 85.74% 87.28% 92.90% 91.19% 79.49% 59.90% 100.00% 74.17% -390.50%
Debt to EBITDA
-7.43 -0.32 -0.37 -0.26 -1.15 -0.85 -0.82 0.00 -1.91 -1.45
Net Debt to EBITDA
-0.56 0.94 1.88 2.67 10.52 2.75 1.02 0.00 5.04 -0.25
Long-Term Debt to EBITDA
-7.43 -0.32 -0.37 -0.12 -0.74 -0.80 -0.82 0.00 -1.91 -1.45
Debt to NOPAT
-8.00 -0.40 -0.44 -0.31 -1.08 -0.91 -1.09 0.00 -2.95 -2.02
Net Debt to NOPAT
-0.61 1.16 2.24 3.11 9.89 2.97 1.36 0.00 7.78 -0.35
Long-Term Debt to NOPAT
-8.00 -0.40 -0.44 -0.14 -0.70 -0.86 -1.09 0.00 -2.95 -2.02
Altman Z-Score
1.79 7.26 7.10 10.65 24.30 5.78 13.73 10.35 8.40 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 110.29% -2,144.35%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
5.82 2.15 3.24 3.48 5.75 3.32 3.44 5.60 8.98 3.74
Quick Ratio
5.55 1.82 2.95 3.25 5.56 3.16 3.24 0.61 8.74 3.51
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-112 -134 -80 -92 -48 -51 -92 39 -18 -16
Operating Cash Flow to CapEx
9.99% -123.94% -77.14% -134.51% -101.53% -106.87% -561.64% -418.61% -602.64% -1,007.55%
Free Cash Flow to Firm to Interest Expense
-5.51 -36.79 -19.21 -78.96 -31.74 -31.20 -14.90 11.54 -5.46 -15.09
Operating Cash Flow to Interest Expense
0.17 -13.73 -5.56 -32.30 -9.06 -13.31 -4.74 -4.40 -5.13 -17.00
Operating Cash Flow Less CapEx to Interest Expense
-1.50 -24.80 -12.77 -56.30 -17.98 -25.76 -5.58 -5.46 -5.98 -18.69
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.87 1.12 0.90 0.66 0.65 1.01 1.17 0.73 0.73 0.95
Accounts Receivable Turnover
8.37 8.85 8.53 8.46 9.86 9.83 8.95 8.80 8.55 6.48
Inventory Turnover
13.16 11.05 10.17 14.02 15.03 17.21 0.00 0.00 16.48 12.84
Fixed Asset Turnover
5.16 5.48 6.24 7.16 8.74 12.05 19.06 18.11 19.16 17.75
Accounts Payable Turnover
28.88 24.64 14.34 14.69 11.15 9.97 0.00 0.00 11.73 10.08
Days Sales Outstanding (DSO)
43.61 41.27 42.79 43.17 37.03 37.14 40.80 41.50 42.68 56.33
Days Inventory Outstanding (DIO)
27.74 33.04 35.89 26.03 24.28 21.21 0.00 0.00 22.15 28.43
Days Payable Outstanding (DPO)
12.64 14.82 25.44 24.84 32.74 36.60 0.00 0.00 31.13 36.23
Cash Conversion Cycle (CCC)
58.71 59.49 53.23 44.35 28.57 21.74 40.80 41.50 33.70 48.53
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
140 108 62 62 39 22 8.83 -51 7.67 0.84
Invested Capital Turnover
4.77 5.80 6.66 6.38 8.67 14.03 -7.03 -4.61 15.07 86.46
Increase / (Decrease) in Invested Capital
32 47 -0.14 22 18 13 60 -58 6.83 0.84
Enterprise Value (EV)
2,871 3,179 2,642 3,245 6,546 1,699 1,637 1,288 579 0.00
Market Capitalization
2,822 3,281 2,820 3,463 6,849 1,813 1,680 1,288 664 0.00
Book Value per Share
$2.90 $6.85 $7.96 $9.50 $11.83 $5.09 $2.16 ($6.82) $4.18 ($73.85)
Tangible Book Value per Share
$2.88 $6.83 $7.94 $9.47 $11.80 $5.05 $2.12 ($6.82) $4.14 ($74.48)
Total Capital
737 245 275 301 375 170 87 -157 125 26
Total Debt
646 35 35 21 33 35 35 0.00 32 31
Total Long-Term Debt
646 35 35 9.69 21 33 35 0.00 32 31
Net Debt
49 -102 -178 -218 -302 -114 -43 0.00 -85 5.25
Capital Expenditures (CapEx)
34 40 30 28 14 20 5.18 3.56 2.76 1.79
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.65 -10 -13 -9.80 -11 -18 -4.38 98 -0.75 -1.25
Debt-free Net Working Capital (DFNWC)
535 123 200 229 324 123 74 98 105 24
Net Working Capital (NWC)
535 123 200 218 312 121 74 98 105 24
Net Nonoperating Expense (NNE)
32 36 37 31 13 16 18 10 10.00 7.66
Net Nonoperating Obligations (NNO)
49 -102 -178 -218 -302 -114 -43 106 -85 5.36
Total Depreciation and Amortization (D&A)
27 17 19 18 13 12 1.57 1.51 0.83 0.61
Debt-free, Cash-free Net Working Capital to Revenue
-0.11% -2.10% -3.28% -3.03% -4.30% -8.33% -2.98% 99.24% -1.17% -3.44%
Debt-free Net Working Capital to Revenue
90.38% 25.06% 48.59% 71.04% 122.12% 57.18% 50.22% 99.24% 164.49% 66.56%
Net Working Capital to Revenue
90.38% 25.06% 48.59% 67.43% 117.72% 56.27% 50.22% 99.24% 164.49% 66.56%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($3.63) ($4.04) ($3.88) ($3.46) ($1.58) ($2.16) ($2.02) ($1.30) ($3.95) ($16.57)
Adjusted Weighted Average Basic Shares Outstanding
31.20M 30.53M 29.92M 29.33M 29.16M 26.80M 24.46M 23.45M 22.15M 1.38M
Adjusted Diluted Earnings per Share
($3.63) ($4.04) ($3.88) ($3.46) ($1.58) ($2.16) ($2.02) ($1.30) ($3.95) ($16.57)
Adjusted Weighted Average Diluted Shares Outstanding
31.20M 30.53M 29.92M 29.33M 29.16M 26.80M 24.46M 23.45M 22.15M 1.38M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 ($1.58) ($2.16) ($2.02) ($1.30) ($3.95) ($16.57)
Adjusted Weighted Average Basic & Diluted Shares Outstanding
31.41M 30.98M 30.22M 29.51M 27.75M 25.27M 23.89M 22.63M 5.29M 1.38M
Normalized Net Operating Profit after Tax (NOPAT)
-80 -80 -61 -70 -31 -38 -32 -19 -11 -15
Normalized NOPAT Margin
-13.59% -16.21% -14.85% -21.67% -11.53% -17.86% -21.72% -19.48% -17.02% -41.90%
Pre Tax Income Margin
-19.05% -24.90% -28.20% -31.28% -16.44% -25.40% -34.18% -30.00% -32.62% -62.78%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
-5.60 -34.34 -27.57 -85.39 -27.70 -32.17 -7.19 -7.78 -5.44 -20.43
NOPAT to Interest Expense
-3.96 -24.00 -19.25 -59.85 -20.13 -23.33 -5.21 -5.70 -3.36 -14.30
EBIT Less CapEx to Interest Expense
-7.26 -45.42 -34.78 -109.40 -36.62 -44.62 -8.04 -8.84 -6.29 -22.11
NOPAT Less CapEx to Interest Expense
-5.62 -35.08 -26.46 -83.86 -29.05 -35.78 -6.05 -6.76 -4.21 -15.99
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-22.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for iRhythm Technologies

This table displays calculated financial ratios and metrics derived from iRhythm Technologies' official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
20.27% 24.01% 18.41% 19.27% 18.39% 17.67% 19.96% 21.64% 20.63% 37.67% 21.59%
EBITDA Growth
22.66% 83.20% -78.11% 27.30% 14.96% -124.33% -13.31% 29.31% 10.79% 38.95% -11.98%
EBIT Growth
17.16% 68.33% -77.26% 4.79% 7.58% -103.59% -31.42% 25.65% 21.55% 35.69% 9.73%
NOPAT Growth
14.64% 89.58% -82.24% -21.77% 3.46% -89.30% -30.91% 19.53% 18.63% 35.72% 9.43%
Net Income Growth
32.77% 96.56% -70.31% -8.79% -16.77% -91.60% -26.41% 22.66% 22.72% 37.84% 9.61%
EPS Growth
34.01% 97.60% -66.29% -6.56% -13.95% -89.39% -25.35% 23.75% 24.56% 40.54% 12.35%
Operating Cash Flow Growth
84.83% 220.41% 1,935.70% 358.97% -69.18% -227.00% -67.40% -1,129.03% 20.91% 196.40% -79.24%
Free Cash Flow Firm Growth
92.75% 53.48% -67.75% -225.05% -200.52% -416.41% -104.11% -138.03% -34.57% 68.02% 41.06%
Invested Capital Growth
-8.90% 29.19% 41.79% 94.20% 105.47% 75.78% 36.32% 25.31% 13.33% -0.22% 11.48%
Revenue Q/Q Growth
-3.44% 11.38% -0.34% 12.22% -0.44% 6.35% 0.38% 11.39% -1.05% 8.42% 1.79%
EBITDA Q/Q Growth
-299.66% 85.15% -333.10% 66.75% 14.61% -57.38% -76.79% 61.11% -106.76% 20.51% -10.30%
EBIT Q/Q Growth
-137.42% 72.83% -195.89% 52.82% 10.20% -52.07% -58.92% 54.20% -83.94% 1.84% 10.08%
NOPAT Q/Q Growth
-697.35% 91.88% -118.89% 39.74% 2.66% -41.95% -46.26% 52.23% -90.86% 1.84% 10.08%
Net Income Q/Q Growth
-2,203.08% 97.11% -129.68% 55.97% -18.01% -42.72% -46.72% 52.74% -93.63% 5.84% 10.24%
EPS Q/Q Growth
-3,133.33% 97.97% -127.69% 55.78% -17.60% -40.45% -45.90% 52.71% -95.45% 7.04% 11.25%
Operating Cash Flow Q/Q Growth
-141.03% -21.01% 105.63% 122.76% -225.75% -1,435.45% 126.16% 85.13% -344.54% 242.76% 1,086.29%
Free Cash Flow Firm Q/Q Growth
76.55% 54.31% 27.95% 6.12% -44.65% -64.78% -39.61% 13.20% -158.62% 34.87% -62.81%
Invested Capital Q/Q Growth
7.63% 2.49% -25.29% 10.55% 48.52% 12.48% 2.32% 16.97% 30.57% -12.76% -5.94%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
68.83% 70.02% 68.78% 69.89% 66.34% 65.98% 66.19% 69.46% 67.91% 69.89% 68.28%
EBITDA Margin
-15.69% -3.79% -28.44% -6.55% -22.09% -27.98% -18.91% -10.74% -30.75% -14.68% -20.02%
Operating Margin
-20.52% -2.48% -34.09% -15.52% -28.91% -29.57% -22.15% -15.20% -35.45% -18.38% -20.30%
EBIT Margin
-19.97% -8.12% -33.29% -11.21% -26.67% -31.80% -22.24% -14.05% -34.16% -18.38% -20.30%
Profit (Net Income) Margin
-19.35% -0.81% -31.30% -13.58% -34.61% -29.20% -21.76% -14.89% -35.10% -17.94% -20.65%
Tax Burden Percent
102.21% 112.78% 100.41% 100.97% 100.07% 100.66% 100.72% 101.17% 100.22% 100.36% 100.54%
Interest Burden Percent
94.80% 8.86% 93.63% 119.95% 129.70% 91.23% 97.15% 104.77% 102.50% 97.23% 101.18%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-56.26% -8.30% -114.84% -42.17% -84.53% -120.05% -87.86% -56.88% -140.94% -85.72% -80.64%
ROIC Less NNEP Spread (ROIC-NNEP)
-67.65% -14.07% -77.53% -24.79% -27.40% -112.00% -82.53% -53.36% -133.67% -82.84% -77.30%
Return on Net Nonoperating Assets (RNNOA)
-53.10% 2.47% 15.63% 3.55% 5.83% 69.71% 52.52% 34.09% 90.30% 63.16% 57.95%
Return on Equity (ROE)
-109.35% -5.83% -99.21% -38.62% -78.70% -50.34% -35.34% -22.79% -50.64% -22.56% -22.69%
Cash Return on Invested Capital (CROIC)
-39.41% -90.63% -125.15% -128.73% -139.59% -158.10% -120.23% -105.36% -109.34% -128.93% -141.79%
Operating Return on Assets (OROA)
-13.45% -7.04% -27.63% -8.93% -20.56% -35.55% -23.89% -14.68% -34.55% -16.58% -16.76%
Return on Assets (ROA)
-13.04% -0.70% -25.98% -10.82% -26.68% -32.65% -23.38% -15.56% -35.49% -16.18% -17.05%
Return on Common Equity (ROCE)
-109.35% -5.83% -99.21% -38.62% -78.70% -50.34% -35.34% -22.79% -50.64% -22.56% -22.69%
Return on Equity Simple (ROE_SIMPLE)
-113.45% 0.00% -209.93% -132.66% -143.94% 0.00% -47.73% -44.33% -47.18% 0.00% -53.69%
Net Operating Profit after Tax (NOPAT)
-23 -2.86 -35 -16 -27 -27 -19 -13 -28 -14 -15
NOPAT Margin
-14.36% -1.74% -23.87% -10.87% -20.24% -20.70% -15.51% -10.64% -24.82% -12.87% -14.21%
Net Nonoperating Expense Percent (NNEP)
11.39% 5.77% -37.32% -17.37% -57.13% -8.05% -5.34% -3.52% -7.27% -2.88% -3.34%
Return On Investment Capital (ROIC_SIMPLE)
-3.11% -0.39% - - - -11.19% - - - -5.27% -
Cost of Revenue to Revenue
31.17% 29.98% 31.22% 30.11% 33.66% 34.02% 33.81% 30.54% 32.09% 30.11% 31.72%
SG&A Expenses to Revenue
75.60% 60.71% 70.07% 72.11% 82.36% 75.55% 75.25% 73.65% 90.05% 77.01% 77.55%
R&D to Revenue
13.75% 11.80% 32.37% 13.30% 12.88% 11.63% 13.09% 11.02% 13.32% 11.26% 11.02%
Operating Expenses to Revenue
89.35% 72.51% 102.87% 85.41% 95.24% 95.55% 88.34% 84.67% 103.36% 88.27% 88.57%
Earnings before Interest and Taxes (EBIT)
-32 -13 -49 -17 -35 -42 -28 -17 -38 -21 -21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-25 -6.23 -42 -9.69 -29 -37 -24 -13 -34 -17 -21
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
37.94 31.04 32.31 33.76 39.38 15.62 13.11 14.20 16.89 11.76 15.72
Price to Tangible Book Value (P/TBV)
38.32 31.34 32.71 34.05 39.76 15.68 13.16 14.25 16.96 11.80 15.78
Price to Revenue (P/Rev)
5.32 4.77 4.14 6.23 6.93 6.66 6.10 7.03 8.72 6.86 9.90
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
22.26 20.52 17.46 18.78 21.97 29.36 28.66 32.41 44.83 42.89 50.88
Enterprise Value to Revenue (EV/Rev)
5.42 4.85 4.26 6.39 7.07 6.45 5.84 6.74 8.39 6.43 9.45
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
70.52 846.94 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
7.47 7.11 9.00 6.50 7.13 0.17 0.16 0.16 0.16 0.15 0.15
Long-Term Debt to Equity
7.47 7.11 9.00 6.50 7.13 0.17 0.16 0.16 0.16 0.15 0.15
Financial Leverage
0.78 -0.18 -0.20 -0.14 -0.21 -0.62 -0.64 -0.64 -0.68 -0.76 -0.75
Leverage Ratio
10.37 4.53 4.63 4.17 4.27 1.96 1.92 1.85 1.82 1.75 1.72
Compound Leverage Factor
9.84 0.40 4.33 5.01 5.53 1.79 1.86 1.93 1.87 1.71 1.74
Debt to Total Capital
88.19% 87.67% 90.00% 86.67% 87.71% 14.26% 13.72% 13.50% 13.61% 12.72% 12.74%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
88.19% 87.67% 90.00% 86.67% 87.71% 14.26% 13.72% 13.50% 13.61% 12.72% 12.74%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
11.81% 12.33% 10.00% 13.33% 12.30% 85.74% 86.28% 86.50% 86.39% 87.28% 87.26%
Debt to EBITDA
-8.12 -7.43 -5.79 -6.93 -6.66 -0.32 -0.39 -0.40 -0.39 -0.37 -0.33
Net Debt to EBITDA
-0.80 -0.56 -0.58 -0.90 -0.77 0.94 1.37 1.48 1.60 1.88 1.60
Long-Term Debt to EBITDA
-8.12 -7.43 -5.79 -6.93 -6.66 -0.32 -0.39 -0.40 -0.39 -0.37 -0.33
Debt to NOPAT
-8.41 -8.00 -6.13 -7.20 -7.43 -0.40 -0.47 -0.50 -0.48 -0.44 -0.40
Net Debt to NOPAT
-0.83 -0.61 -0.61 -0.93 -0.87 1.16 1.65 1.85 1.93 2.24 1.92
Long-Term Debt to NOPAT
-8.41 -8.00 -6.13 -7.20 -7.43 -0.40 -0.47 -0.50 -0.48 -0.44 -0.40
Altman Z-Score
2.39 2.15 1.63 2.65 2.76 7.90 7.16 8.73 10.60 7.79 10.88
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
5.71 5.82 6.27 6.92 7.10 2.15 2.29 2.71 3.10 3.24 3.42
Quick Ratio
5.40 5.55 5.99 6.61 6.80 1.82 2.04 2.41 2.76 2.95 3.16
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-8.08 -34 -75 -105 -112 -74 -45 -32 -37 -14 -22
Operating Cash Flow to CapEx
-83.78% 281.01% 275.61% 139.49% -532.21% -118.16% 13.16% -48.65% -365.11% 177.30% 57.93%
Free Cash Flow to Firm to Interest Expense
-2.47 -10.38 -22.66 -31.62 -10.67 -78.75 -48.51 -38.72 -39.07 -14.17 -35.89
Operating Cash Flow to Interest Expense
-2.41 5.79 7.31 3.57 -4.98 -16.97 1.29 -5.50 -32.37 12.41 5.98
Operating Cash Flow Less CapEx to Interest Expense
-5.29 3.73 4.66 1.01 -5.91 -31.34 -8.51 -16.79 -41.24 5.41 -4.34
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.67 0.87 0.83 0.80 0.77 1.12 1.07 1.05 1.01 0.90 0.83
Accounts Receivable Turnover
7.26 8.37 8.79 7.86 7.37 8.85 8.55 8.33 8.20 8.53 6.71
Inventory Turnover
12.97 13.16 12.56 11.79 10.85 11.05 10.65 9.72 9.32 10.17 10.31
Fixed Asset Turnover
5.09 5.16 5.11 5.18 5.28 5.48 5.62 5.80 6.17 6.24 6.08
Accounts Payable Turnover
18.58 28.88 24.33 17.13 18.61 24.64 20.48 21.39 17.70 14.34 20.48
Days Sales Outstanding (DSO)
50.26 43.61 41.55 46.42 49.53 41.27 42.69 43.80 44.50 42.79 54.42
Days Inventory Outstanding (DIO)
28.15 27.74 29.06 30.97 33.65 33.04 34.26 37.53 39.15 35.89 35.39
Days Payable Outstanding (DPO)
19.65 12.64 15.00 21.31 19.61 14.82 17.82 17.06 20.62 25.44 17.83
Cash Conversion Cycle (CCC)
58.76 58.71 55.60 56.08 63.57 59.49 59.13 64.27 63.02 53.23 71.99
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
151 140 136 183 165 108 96 94 80 62 71
Invested Capital Turnover
3.92 4.77 4.81 3.88 4.18 5.80 5.67 5.34 5.68 6.66 5.67
Increase / (Decrease) in Invested Capital
-15 32 40 89 85 47 26 19 9.46 -0.14 7.27
Enterprise Value (EV)
3,352 2,871 2,384 3,432 3,630 3,179 2,759 3,049 3,606 2,642 3,593
Market Capitalization
3,288 2,822 2,319 3,348 3,555 3,281 2,882 3,179 3,748 2,820 3,762
Book Value per Share
$2.76 $2.90 $2.30 $3.19 $2.91 $6.85 $7.19 $7.35 $7.34 $7.96 $7.97
Tangible Book Value per Share
$2.73 $2.88 $2.27 $3.16 $2.88 $6.83 $7.16 $7.32 $7.31 $7.94 $7.94
Total Capital
734 737 718 744 734 245 255 259 257 275 274
Total Debt
647 646 646 645 644 35 35 35 35 35 35
Total Long-Term Debt
647 646 646 645 644 35 35 35 35 35 35
Net Debt
64 49 65 84 75 -102 -124 -130 -141 -178 -169
Capital Expenditures (CapEx)
9.42 6.84 8.83 8.49 9.78 14 9.09 9.40 8.42 7.09 6.33
Debt-free, Cash-free Net Working Capital (DFCFNWC)
4.08 -0.65 5.77 18 22 -10 -26 -12 -4.35 -13 -1.28
Debt-free Net Working Capital (DFNWC)
525 535 528 580 591 123 132 153 172 200 202
Net Working Capital (NWC)
525 535 528 580 591 123 132 153 172 200 202
Net Nonoperating Expense (NNE)
7.91 -1.53 11 4.02 19 11 7.79 5.27 11 5.71 6.69
Net Nonoperating Obligations (NNO)
64 49 65 84 75 -102 -124 -130 -141 -178 -169
Total Depreciation and Amortization (D&A)
6.78 7.11 7.15 6.91 6.05 5.06 4.15 4.11 3.80 4.17 0.29
Debt-free, Cash-free Net Working Capital to Revenue
0.66% -0.11% 1.03% 3.38% 4.19% -2.10% -5.60% -2.66% -1.01% -3.28% -0.34%
Debt-free Net Working Capital to Revenue
84.82% 90.38% 94.25% 107.92% 115.09% 25.06% 27.92% 33.79% 40.00% 48.59% 53.21%
Net Working Capital to Revenue
84.82% 90.38% 94.25% 107.92% 115.09% 25.06% 27.92% 33.79% 40.00% 48.59% 53.21%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.97) ($0.03) ($1.48) ($0.65) ($1.47) ($1.25) ($0.89) ($0.61) ($1.29) ($0.66) ($0.71)
Adjusted Weighted Average Basic Shares Outstanding
31.59M 31.20M 31.26M 31.15M 31.03M 30.53M 30.61M 30.50M 30.30M 29.92M 30.06M
Adjusted Diluted Earnings per Share
($0.97) ($0.03) ($1.48) ($0.65) ($1.47) ($1.25) ($0.89) ($0.61) ($1.29) ($0.66) ($0.71)
Adjusted Weighted Average Diluted Shares Outstanding
31.59M 31.20M 31.26M 31.15M 31.03M 30.53M 30.61M 30.50M 30.30M 29.92M 30.06M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
31.93M 31.41M 31.30M 31.24M 31.10M 30.98M 30.65M 30.58M 30.47M 30.22M 30.11M
Normalized Net Operating Profit after Tax (NOPAT)
-23 -2.86 -35 -16 -27 -27 -19 -13 -28 -14 -15
Normalized NOPAT Margin
-14.36% -1.74% -23.56% -10.87% -20.24% -20.70% -15.51% -10.64% -24.82% -12.87% -14.21%
Pre Tax Income Margin
-18.93% -0.72% -31.17% -13.45% -34.59% -29.01% -21.61% -14.72% -35.02% -17.87% -20.54%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-9.68 -4.02 -14.76 -5.01 -3.37 -44.78 -29.89 -20.96 -40.08 -20.43 -34.34
NOPAT to Interest Expense
-6.96 -0.86 -10.58 -4.86 -2.55 -29.15 -20.84 -15.88 -29.11 -14.30 -24.04
EBIT Less CapEx to Interest Expense
-12.56 -6.08 -17.41 -7.58 -4.30 -59.15 -39.70 -32.25 -48.94 -27.43 -44.66
NOPAT Less CapEx to Interest Expense
-9.84 -2.92 -13.23 -7.42 -3.49 -43.51 -30.65 -27.17 -37.97 -21.30 -34.35
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% -22.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About iRhythm Technologies' Financials

When does iRhythm Technologies's financial year end?

According to the most recent income statement we have on file, iRhythm Technologies' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has iRhythm Technologies' net income changed over the last 9 years?

iRhythm Technologies' net income appears to be on an upward trend, with a most recent value of -$113.29 million in 2024, rising from -$22.80 million in 2015. The previous period was -$123.41 million in 2023. Find out what analysts predict for iRhythm Technologies in the coming months.

What is iRhythm Technologies's operating income?
iRhythm Technologies's total operating income in 2024 was -$115.51 million, based on the following breakdown:
  • Total Gross Profit: $407.53 million
  • Total Operating Expenses: $523.04 million
How has iRhythm Technologies revenue changed over the last 9 years?

Over the last 9 years, iRhythm Technologies' total revenue changed from $36.14 million in 2015 to $591.84 million in 2024, a change of 1,537.6%.

How much debt does iRhythm Technologies have?

iRhythm Technologies' total liabilities were at $840.54 million at the end of 2024, a 276.8% increase from 2023, and a 1,882.4% increase since 2015.

How much cash does iRhythm Technologies have?

In the past 9 years, iRhythm Technologies' cash and equivalents has ranged from $0.00 in 2017 to $419.60 million in 2024, and is currently $419.60 million as of their latest financial filing in 2024.

How has iRhythm Technologies' book value per share changed over the last 9 years?

Over the last 9 years, iRhythm Technologies' book value per share changed from -73.85 in 2015 to 2.90 in 2024, a change of -103.9%.



This page (NASDAQ:IRTC) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners